Lx. Fu et al., DIABETES-INDUCED CHANGES IN THE GI-MODULATED MUSCARINIC RECEPTOR-ADENYLYL CYCLASE SYSTEM IN RAT MYOCARDIUM, Pharmacology & toxicology, 75(3-4), 1994, pp. 186-193
The inhibitory guanine nucleotide binding regulatory protein (Gi)-medi
ated muscarinic receptor-adenylyl cyclase system was studied in myocar
dium from adult male Wistar rats with 10 weeks of diabetes induced by
a single intravenous injection of streptozotocin (60 mg/kg). Neither t
he messenger ribonucleic acid level nor the amount of Gi was changed i
n the streptozotocin diabetic group as compared to the control group.
The activity of the adenylyl cyclase stimulated by guanyliminodiphosph
ate was decreased by 48% in the streptozotocin diabetic group whereas
stimulated activities of adenylyl cyclase by sodium fluoride and forsk
olin remained unchanged. The inhibition of forskolin-stimulated adenyl
yl cyclase activity by carbachol was more potent in membranes from the
streptozotocin diabetic group than that in membranes from the control
group. The competition binding curve between (H-3)-quinuclidinyl benz
ilate and carbachol obtained from the streptozotocin diabetic group wa
s shifted to the left as compared Co the control group. These results
suggest that the myocardium of streptozotocin-induced diabetic rats ex
hibited an increase in Gi function as demonstrated by the increased in
hibition of guanyliminodiphosphate-mediated adenylyl cyclase and the s
uperhigh affinity for carbachol of the muscarinic receptors. As there
were signs, similar to those seen in clinical heart failure, in the st
reptozotocin diabetic group, these results demonstrate that functional
alteration of Gi might underlie, at least in part, the cardiac dysfun
ction that is associated with diabetes.